Yazarların “Radyoterapiyle Kombine Edilen Temozolomid Duyarlı Pitüiter Atipik Adenom veya Karsinom: Erken Tanımlama ve Yönetimle İlgili Bir Olgu Sunumu” Makalesine Cevabı

Kaynakça (1)

1. Curtò L, Torre ML, Ferraù F, Pitini V, Altavilla G, Granata F, Longo M, Hofland LJ, Trimarchi F, Cannavò S: Temozolomideinduced shrinkage of a pituitary carcinoma causing Cushing’s disease. Report of a case and literature review. Scientific World Journal 10: 2132-2138, 2010 2. Kovacs K, Scheithauer BW, Lombardero M, McLendon RE, Syro LV, Uribe H, Ortiz LD, Penagos LC: MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy. Acta Neuropathol 115:261–262, 2008 3. Raverot G, Castinetti F, Jouanneau E, Morange I, FigarellaBranger D, Dufour H, Trouillas J, Brue T: Pituitary carcinomas and aggressive pituitary tumours: Merits and pitfalls of temozolomide treatment. Clin Endocrinol (Oxf) 76:769–775, 2012 4. Zhong C, Yin S, Zhou P, Jiang S: Pituitary atypical adenoma or carcinoma sensitive to temozolomide combined with radiation therapy: A case report of early identification and management. Turk Neurosurg 24:963-966, 2014